some years ago (and i will sift through the threads to get the timeframe) there was a fungal product being developed in a JV with Hexima. At that time a current board member was also on the board of Hexima - but eventually resigned from that post. There was IMO a complete lack of information provided to SH's at that time when the JV was finalised and Hexima from what i understood got whatever was developed (or whatever stage it was developed to). From my research i was unable to locate costs of that project and who got what when the JV finished. It was mentioned as a JV in one report - glosssed over as being finished in another and no real info been provided regarding that (from what i could ascertain at the time). Therefore one would think that they would have already had a head start on any fungal creams given that it was being developed at that time. things are moving oh so slowly here and cashburn becoming worrisome given the lack of returns to date. lets see how things pan out but i expect a CR at the most unexpected moment and at a time when there is still cash on hand so as to provide a non-desperate look at the time of the CR. lets see - all IMO.
ACR Price at posting:
12.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)